可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]King DJ,Kelton JG.Heparinassociated thrombocytopenia[J].Ann Intern Med,1984,100(4):535-540.
[2]Levy JH,Hursting MJ.Heparininduced thrombocytopenia,a prothrombotic disease[J].Hematol Oncol Clin North Am,2007,21(1):65-88.
[3]Martel N,Lee J,Wells PS.Risk for heparininduced thrombocytopenia with unfractionated and lowmolecularweight heparin thromboprophylaxis: a metaanalysis[J].Blood,2005,106(8):2710-2715.
[4]Aster RH.Heparininduced thrombocytopenia and thrombosis[J].N Engl J Med,1995,332(20):1374-1376.
[5]Wallis DE,Workman DL,Lewis BE,et al.Failure of early heparin cessation as treatment for heparininduced thrombocytopenia[J].Am J Med,1999,106(6):629-635.
[6]Warkentin TE.Management of heparininduced thrombocytopenia: a critical comparison of lepirudin and argatroban[J].Thromb Res,2003,110(2-3):73-82.
[7]Warkentin TE,Kelton JG.Temporal aspects of heparininduced thrombocytopenia[J].N Engl J Med,2001,344(17):1286-1292.
[8]Warkentin TE,Greinacher A,Koster A,et al.Treatment and prevention of heparininduced thrombocytopenia: American College of Chest Physicians EvidenceBased Clinical Practice Guidelines (8th Edition)[J].Chest,2008,133(6 Suppl):340S-380S.